Blue Jet Healthcare slides 15% in two days after Q1 margin drop and profit miss; brokerages cut FY26–27 estimates.

• Stock fell 5% Wednesday after a 10% drop on Tuesday, marking the steepest 2-day fall since November 2023 listing.
• Gross margin shrank to 48.4% from 54.7% Q/Q; Emkay cites inventory reduction as the key drag.
• Emkay cuts target to ₹1,050; stock still rated “buy” with median TP at ₹965; up 52% YTD.